About GAVI
Who we are
Task Forces

GAVI Task Force on Research and Development (R&DTF)

The GAVI Task Force on Research and Development (R&DTF) is co-chaired by WHO, the University of Maryland and Chiron Vaccines. Objectives of the task force include:

• Support the GAVI objectives to:
• Accelerate the development and introduction of new vaccines and technologies
• Accelerate R&D efforts for vaccines needed primarily in developing countries.
• Catalyse action and coordinate global initiatives for
• a limited number of disease specific programmes which can most effectively contribute to the Task Forceís ultimate goals
• a limited number of new technologies which will improve safety, effectiveness, utility or performance of immunization in developing countries
• Promoting private-public sector partnerships in R&D, and involving the private sector in R&D initiatives in developing countries
• Establishing forums for policy dialogue and information sharing

Current members of the task force:

• Dr. Yasuhiro Suzuki, WHO
• Dr. Rino Rappuoli, Chiron Vaccines
• Dr. Myron (Mike) Levine, Univ. of Maryland, USA
• Dr. Tore Godal, GAVI Secretariat
• Dr. Barry Bloom, Harvard School of Public Health, USA
• Dr. Fred Newton Binka, Ghana Health Ministry
• Dr. Rosa Lagos, Hospital Roberto del Rio, Chile
• Professor Gus Nossal, University of Melbourne, Australia
• Dr. Punnee Pitisuttitham, Mahidol University, Thailand
• Dr. Margaret Liu, Bill & Melinda Gates Foundation, USA
• Dr. Anders Nordstrom, Gothenburg University, Sweden